MEK and RAF inhibitors for BRAF-mutated cancers.

Expert reviews in molecular medicine

Volumn 14, Issue , 2012, Pages

  Belden, Sarah ^a   Flaherty, Keith T ^b  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE; PROTEIN KINASE INHIBITOR; RAS PROTEIN;

DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HUMAN; MELANOMA; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; MAP KINASE SIGNALING SYSTEM; MELANOMA; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS;

MLCS; MLOWN;

EID: 84875073097     PISSN: None     EISSN: 14623994     Source Type: Journal    
DOI: 10.1017/erm.2012.11     Document Type: Review

References (0)